V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20221782 | 20084316 | 1.66 | 53.2 | Palliative (P) | 2018-09-20 | 2018-10-04 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100325734 |
| 20221784 | 20084317 | 1.73 | 65.9 | Disease modification (D) | 2019-02-21 | 2019-02-27 | Enzalutamide | 2 | N | ENZALUTAMIDE | 100031439 |
| 20221798 | 20084318 | 1.77 | 129 | Palliative (P) | 2017-11-03 | 2017-11-03 | TRASTUZUMAB | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101138354 |
| 20221807 | 20084319 | 1.67 | 101.8 | Curative (C) | 2017-07-24 | 2017-07-24 | ECF | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100902443 |
| 20221809 | 20084320 | 1.58 | 65 | null | 2018-05-21 | 2018-05-22 | Enzalutamide | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 100742662 |
| 20221813 | 20084321 | null | 50 | Neo-adjuvant (N) | 2019-11-05 | 2019-11-05 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100248131 |
| 20221814 | 20084322 | 1.54 | 102.8 | null | 2019-03-04 | 2019-03-25 | ECF | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101047669 |
| 20221826 | 20084323 | 1.71 | 77.8 | Neo-adjuvant (N) | 2019-12-02 | 2019-12-04 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101446296 |
| 20221832 | 20084324 | 1.64 | null | Palliative (P) | 2018-02-13 | 2018-02-16 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101737447 |
| 20221835 | 20084325 | 1.69 | null | Palliative (P) | 2017-12-10 | 2017-12-10 | Enzalutamide | N | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101310488 |
| 20221836 | 20084326 | 1.74 | null | 03 | 2017-09-24 | 2017-09-29 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 101338877 |
| 20221840 | 20084327 | null | 0 | Palliative (P) | 2016-11-29 | 2016-12-20 | CARBOPLATIN + PACLITAXEL + RT | 2 | N | CARBOPLATIN + PACLITAXEL + RT | 100856641 |
| 20221844 | 20084328 | 1.61 | 63.4 | null | null | 2018-04-19 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 101270491 |
| 20221853 | 20084329 | 1.55 | 56 | null | 2018-03-10 | 2018-04-06 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 100772706 |
| 20221859 | 20084330 | 1.81 | 71 | 03 | 2017-06-19 | 2017-06-22 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100881415 |
| 20221860 | 20084331 | 1.6 | 51 | Curative (C) | 2015-08-25 | 2015-08-26 | Enzalutamide | 02 | null | MITOMYCIN INTRAVESICULAR | 100367509 |
| 20221861 | 20084332 | 1.69 | 51.2 | Neo-adjuvant (N) | 2014-06-05 | 2014-06-05 | Enzalutamide | 02 | Y | CAPECITABINE + CISPLATIN + RT | 101342155 |
| 20221865 | 20084333 | 1.6 | null | Curative (C) | 2020-02-05 | 2020-02-05 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100657791 |
| 20221870 | 20084334 | 0 | 0 | Curative (C) | 2018-01-03 | 2018-01-10 | Enzalutamide | 02 | N | ECF | 100876326 |
| 20221871 | 20084335 | 1.6 | 73.8 | Neo-adjuvant (N) | 2017-12-30 | 2018-01-05 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + RT | 100036957 |
| 20221872 | 20084336 | 0 | 0 | Palliative (P) | 2018-03-30 | 2018-04-28 | Enzalutamide | null | N | OXALIPLATIN + RALTITREXED | 101483998 |
| 20221873 | 20084337 | 1.68 | 94.9 | null | 2019-01-24 | 2019-01-25 | Enzalutamide | 02 | null | TRASTUZUMAB | 100798856 |
| 20221882 | 20084338 | 1.6 | 64 | Curative (C) | null | 2021-02-13 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100383880 |
| 20221883 | 20084339 | 1.7 | 126.2 | Curative (C) | 2016-06-13 | 2016-07-11 | Enzalutamide | null | Y | ECF | 100196174 |
| 20221885 | 20084340 | null | 105 | Neo-adjuvant (N) | 2018-04-10 | 2018-04-11 | Enzalutamide | 02 | Y | ENZALUTAMIDE | 101695733 |
| 20221891 | 20084341 | 1.67 | 49 | null | 2018-03-12 | 2018-03-30 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100519023 |
| 20221892 | 20084342 | 1.78 | 100 | Adjuvant (A) | 2017-05-01 | 2017-05-26 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100661654 |
| 20221897 | 20084343 | 1.7 | 85.1 | Curative (C) | 2018-06-02 | 2018-06-12 | Enzalutamide | 02 | Y | ATEZOLIZUMAB + BEVACIZUMAB | 100382815 |
| 20221909 | 20084344 | 1.55 | 120.9 | Palliative (P) | 2016-11-02 | 2016-11-05 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100923218 |
| 20221911 | 20084345 | 1.8 | 84.85 | Neo-adjuvant (N) | 2016-04-07 | 2016-04-09 | Enzalutamide | 02 | Y | CETUXIMAB | 100526766 |
| 20221915 | 20084346 | 1.62 | 47 | Adjuvant (A) | 2018-01-24 | 2018-01-27 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100274151 |
| 20221917 | 20084347 | 1.6 | 73.3 | Palliative (P) | null | 2016-08-03 | Capecitabine + Cisplatin + RT | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100505012 |
| 20221923 | 20084348 | 1.68 | 43 | Palliative (P) | null | 2016-05-19 | Mitomycin Intravesical | null | N | MITOMYCIN INTRAVESICULAR | 101193022 |
| 20221934 | 20084349 | null | 74 | Curative (C) | 2018-08-18 | 2018-08-26 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101488497 |
| 20221935 | 20084350 | 0 | 0 | Palliative (P) | 2016-08-22 | 2016-08-24 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101037830 |
| 20221937 | 20084351 | 1.56 | 65.1 | Palliative (P) | 2016-05-31 | 2016-06-01 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100530051 |
| 20221938 | 20084352 | 1.77 | 64.45 | null | 2016-04-29 | 2016-04-29 | Enzalutamide | 02 | null | CETUXIMAB | 101568926 |
| 20221945 | 20084353 | 1.94 | 87.6 | Palliative (P) | 2019-01-08 | 2019-01-11 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100034724 |
| 20221947 | 20084354 | 1.84 | 82.2 | Curative (C) | 2014-04-04 | 2014-04-04 | Enzalutamide | 02 | N | CISPLATIN | 100612789 |
| 20221952 | 20084355 | 1.83 | 73.3 | Curative (C) | 2018-03-22 | 2018-04-09 | LUTETIUM-177 | 02 | Y | LUTETIUM-177 | 101706479 |
| 20221958 | 20084356 | 1.69 | 97.9 | Curative (C) | 2017-06-12 | 2017-06-28 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101325979 |
| 20221959 | 20084357 | 1.7 | 67.5 | Curative (C) | 2017-11-27 | 2017-12-05 | Enzalutamide | 02 | Y | CETUXIMAB + OXALIPLATIN + MDG | 101033260 |
| 20221967 | 20084358 | 1.6 | 73.4 | Curative (C) | null | 2016-08-12 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101479491 |
| 20221970 | 20084359 | 1.57 | null | Neo-adjuvant (N) | 2020-01-11 | 2020-01-18 | CARBOPLATIN + PACLITAXEL + RT | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101138077 |
| 20221972 | 20084360 | 1.63 | 80.4 | Palliative (P) | 2019-08-13 | 2019-08-28 | CARBOPLATIN + PACLITAXEL + RT | N | N | CARBOPLATIN + PACLITAXEL + RT | 100576906 |
| 20221976 | 20084361 | null | null | Palliative (P) | 2018-09-26 | 2018-10-23 | Cisplatin | 02 | N | CISPLATIN | 101681142 |
| 20221977 | 20084362 | 1.58 | 101.9 | null | 2016-07-23 | 2016-07-25 | Capecitabine + Cisplatin + RT | null | null | TRASTUZUMAB | 100127787 |
| 20221986 | 20084363 | 1.65 | 84 | Palliative (P) | 2017-05-31 | 2017-06-08 | Enzalutamide | 02 | N | CISPLATIN | 101130408 |
| 20221988 | 20084364 | 1.7 | 70.9 | Palliative (P) | 2021-05-17 | 2021-05-18 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101194026 |
| 20221992 | 20084365 | 1.8 | 43.6 | null | 2020-02-15 | 2020-02-15 | Enzalutamide | N | null | OCTREOTIDE | 100777876 |